Find clinical trials for Heart Disease in Cincinnati, OH
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Heart Disease trials near Cincinnati, OH, USA:
Atrial fibrillation is an abnormal beating of the heart that can lead to stroke or heart failure. Structural heart diseases...
Cincinnati, Ohio, United StatesĀ and 2 other locations
Acute kidney injury (AKI) following cardiac surgery for congenital heart defects (CHD) in children affects up to 60% of high risk-p...
Phase 3
Cincinnati, Ohio, United States
The purpose of this study is to evaluate the device performance and monitor the safety and effectiveness of the Berlin Heart EXCOR Active Dr...
Cincinnati, Ohio, United StatesĀ and 10 other locations
The objective of ENVISION is to evaluate the safety and effectiveness of the Navitor Transcatheter Aortic Valve Implantation (TAVI) System for treati...
Cincinnati, Ohio, United StatesĀ and 61 other locations
intracoronary infusion of AB-1002 in patients with NYHA Class III heart failure. Patients with non-ischemic cardiomyopathy will be enrolled ...
Phase 1
Cincinnati, Ohio, United StatesĀ and 3 other locations
The purpose of this study is to characterize the functionality of transcatheter implantation of the Medtronic Harmony Transcatheter Pulmonary Valve (...
Cincinnati, Ohio, United StatesĀ and 21 other locations
To demonstrate the safety and effectiveness of the Edwards Alterra Adaptive Prestent in conjunction with the Edwards SAPIEN 3 Transcatheter Heart...
Cincinnati, Ohio, United StatesĀ and 13 other locations
PumpKIN is a multicenter, prospective, single-arm feasibility study; Evaluating the investigational Jarvik 2015 VAD in pediatric patients with heart...
Early Phase 1
Cincinnati, Ohio, United StatesĀ and 6 other locations
native aortic regurgitation who are judged by a multi-disciplinary heart team to be eligible for the device and to be at high risk for open ...
Cincinnati, Ohio, United StatesĀ and 8 other locations
This study will evaluate the clinical efficacy and safety of udenafil, an orally administered, potent and selective inhibitor of PDE5, versus placebo...
Phase 3
Cincinnati, Ohio, United StatesĀ and 39 other locations
Clinical trials
Research sites
Resources
Legal